Come and join us across the globe
Dr. Marc Ribó
Interventional Neuroradiologist
Vall d'Hebron Hospital
Barcelona, Spain
Join Dr. Marc Ribó as he speaks about the SPERO study, delving into patient selection criteria, study results, recanalization rates with Nimbus™ devices compared to conventional devices, and the future prospects for clot identification and device selection.
To go further, consult the results published at ESOC .
Supported by
